Klisyri Ointment
Product Images NDC 16110-391

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Klisyri (NDC 16110-391). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Almirall, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Klisyri 01)

FDA Label Image

Packet Label (Klisyri 02)

Packet Label (Klisyri 02)
This text appears to be a label of a medication called Klisyri (tirbanibulin) ointment, 1%, manufactured by Almirall, LLC located in Exton, PA. The label includes dosage information as well as instructions to discard unused portion and to keep it out of reach of children. It also contains important identification numbers such as NDC 16110-391-25 and (01)00316110391250. However, there are some unclear characters and symbols in the text.*
FDA Label Image

Carton Label (Klisyri 03)

Carton Label (Klisyri 03)
This product is an ointment containing 5 packets with 1% strength. It is meant for topical application and requires a prescription. The product has an expiration date of 06/2025. Product details including GTIN and manufacturer details are provided on the carton. The rest of the text appears to be difficult to decipher with strange characters.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.